Portal de investigación
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Valcárcel D
- Sánchez-Ortega I
- Brunet S
- Esteve J
- Ribera JM
- Tormo M
- Duarte R
- Llorente A
- Torres JP
- Guardia R
- Sierra AJ
- CETLAM Group
Grupos
Abstract
A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed.
Datos de la publicación
- ISSN/ISSNe:
- 0008-543X, 1097-0142
- Tipo:
- Article
- Páginas:
- 410-417
- DOI:
- 10.1002/cncr.26273
- PubMed:
- 21717435
- Factor de Impacto:
- 2,962 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
CANCER WILEY
Citas Recibidas en Web of Science: 22
Documentos
- No hay documentos
Filiaciones
Campos de Estudio
Cita
Valcárcel D,MONTESINOS P,Sánchez I,Brunet S,Esteve J,MARTÍNEZ D,Ribera JM,Tormo M,BUENO J,Duarte R,Llorente A,Torres JP,Guardia R,SANZ MA,Sierra AJ,CETLAM G. A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia. Cancer. 2012. 118. (2):p. 410-417. IF:5,201. (1).